Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)Sponsor and Collaborators
Samsung Medical Center
Contact
Kyu-Sung Lee, PhD
82-2-3410-3554
ksleedr@skku.edu
Principal Investigator
Kyu-Sung Lee, PhD
Samsung Medical Center
ClinicalTrials.gov Identifier
NCT00922506
